Schultes Birgit C (CIK 2051419) reported 4 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-03). Recent activity: Buy NTLA (39,200 shares), Sell NTLA (8,508 shares), Sell NTLA (31 shares), Buy NTLA (37,600 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-03 | Intellia Therapeutics, Inc. (NTLA) | EVP, Chief Scientific Officer | Buy | 39,200 | $0 |
| 2026-01-07 | Intellia Therapeutics, Inc. (NTLA) | EVP, Chief Scientific Officer | Sell | 8,508 | $78,359 |
| 2025-10-03 | Intellia Therapeutics, Inc. (NTLA) | EVP, Chief Scientific Officer | Sell | 31 | $539 |
| 2025-03-04 | Intellia Therapeutics, Inc. (NTLA) | EVP, Chief Scientific Officer | Buy | 37,600 | $0 |
Source: SEC Form 4 filings · as of 2026-03-03